358 related articles for article (PubMed ID: 22298070)
1. [Bone and cartilage destruction in rheumatoid arthritis].
Komatsu N; Takayanagi H
Clin Calcium; 2012 Feb; 22(2):179-85. PubMed ID: 22298070
[TBL] [Abstract][Full Text] [Related]
2. [Mechanism of bone destruction and the contribution of T lymphocytes].
Komatsu N
Nihon Rinsho; 2016 Jun; 74(6):907-12. PubMed ID: 27311177
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune arthritis: the interface between the immune system and joints.
Komatsu N; Takayanagi H
Adv Immunol; 2012; 115():45-71. PubMed ID: 22608255
[TBL] [Abstract][Full Text] [Related]
4. Osteoclasts in arthritis and Th17 cell development.
Okamoto K; Takayanagi H
Int Immunopharmacol; 2011 May; 11(5):543-8. PubMed ID: 21081190
[TBL] [Abstract][Full Text] [Related]
5. [Involvement of osteoclasts in cartilage and bone destruction in rheumatoid arthritis].
Hikita A; Tanaka S
Nihon Rinsho; 2005 Jan; 63 Suppl 1():84-6. PubMed ID: 15799323
[No Abstract] [Full Text] [Related]
6. [Molecular mechanisms of bone destruction in rheumatoid arthritis].
Nanki T
Clin Calcium; 2007 Apr; 17(4):510-6. PubMed ID: 17404479
[TBL] [Abstract][Full Text] [Related]
7. Early structural changes in cartilage and bone are required for the attachment and invasion of inflamed synovial tissue during destructive inflammatory arthritis.
Korb-Pap A; Stratis A; Mühlenberg K; Niederreiter B; Hayer S; Echtermeyer F; Stange R; Zwerina J; Pap T; Pavenstädt H; Schett G; Smolen JS; Redlich K
Ann Rheum Dis; 2012 Jun; 71(6):1004-11. PubMed ID: 22258493
[TBL] [Abstract][Full Text] [Related]
8. [RANKL signal and osteoimmunology].
Nakashima T; Takayanagi H
Clin Calcium; 2011 Aug; 21(8):1131-40. PubMed ID: 21814017
[TBL] [Abstract][Full Text] [Related]
9. [Animal models for bone and joint disease. Osteoimmunology and animal models for rheumatoid arthritis].
Komatsu N; Takayanagi H
Clin Calcium; 2011 Feb; 21(2):269-76. PubMed ID: 21289424
[TBL] [Abstract][Full Text] [Related]
10. [Rheumatoid arthritis and cytokines].
Kaneko S; Kondo Y; Yokosawa M; Sumida T
Nihon Rinsho; 2016 Jun; 74(6):913-8. PubMed ID: 27311178
[TBL] [Abstract][Full Text] [Related]
11. [Mechanism of the bone destruction in rheumatoid arthritis].
Nakamura M; Tanaka S
Nihon Rinsho; 2005 Sep; 63(9):1571-3. PubMed ID: 16164213
[TBL] [Abstract][Full Text] [Related]
12. [Osteoclast differentiation and activation].
Takayanagi H
Clin Calcium; 2007 Apr; 17(4):484-92. PubMed ID: 17404476
[TBL] [Abstract][Full Text] [Related]
13. [Immune molecules and the mechanism of joint destruction].
Komatsu N
Clin Calcium; 2016 May; 26(5):683-9. PubMed ID: 27117613
[TBL] [Abstract][Full Text] [Related]
14. The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis.
Noss EH; Brenner MB
Immunol Rev; 2008 Jun; 223():252-70. PubMed ID: 18613841
[TBL] [Abstract][Full Text] [Related]
15. A novel model of fibroblast-mediated cartilage destruction.
Sack U; Hirth A; Funke B; Wiedemeyer K; Lange F; Tröltzsch M; Tannapfel A; Gebhardt R; Emmrich F; Lehmann J
Scand J Immunol; 2005 Jan; 61(1):18-28. PubMed ID: 15644119
[TBL] [Abstract][Full Text] [Related]
16. FLICE-inhibitory protein expression in synovial fibroblasts and at sites of cartilage and bone erosion in rheumatoid arthritis.
Schedel J; Gay RE; Kuenzler P; Seemayer C; Simmen B; Michel BA; Gay S
Arthritis Rheum; 2002 Jun; 46(6):1512-8. PubMed ID: 12115181
[TBL] [Abstract][Full Text] [Related]
17. [Role of osteoclasts in bone destruction in rheumatoid arthritis].
Suzuki Y
Nihon Rinsho Meneki Gakkai Kaishi; 2001 Jun; 24(3):87-97. PubMed ID: 16578961
[No Abstract] [Full Text] [Related]
18. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
19. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
[TBL] [Abstract][Full Text] [Related]
20. Immune-bone interplay in the structural damage in rheumatoid arthritis.
Komatsu N; Takayanagi H
Clin Exp Immunol; 2018 Oct; 194(1):1-8. PubMed ID: 30022480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
